Clinical trial
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
NCT00048958 · Alliance for Clinical Trials in Oncology, Other · Active, not recruiting
Key facts
| NCT number | NCT00048958 |
|---|---|
| Title | Cytogenetic Studies in Acute Leukemia and Multiple Myeloma |
| Official title | Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Acute Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple Myeloma |
| Intervention type | Genetic |
| Interventions | cytogenetic analysis |
| Enrollment | 9,000 |
| Start date | Jun 1, 1984 |
| Primary completion | Jan 1, 2100 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 31, 2024 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: